Mefruside

Mefruside
	File:Mefruside.png
Systematic (IUPAC) name
	4-chloro-N1-methyl-N1-[(2-methyltetrahydrofuran-2-yl)methyl]benzene-1,3-disulfonamide
Clinical data
AHFS/Drugs.com	International Drug Names
Legal status	℞ (Prescription only);
Routes of; administration	Oral
Identifiers
CAS Number	7195-27-9
ATC code	C03BA05 (WHO)
PubChem	CID: 4047
ChemSpider	3907
UNII	X1NS9SNS92
KEGG	D01877
Chemical data
Formula	C13H19ClN2O5S2
Molecular mass	382.88 g/mol
	SMILES CC1(CCCO1)CN(C)S(=O)(=O)C2=CC(=C(C=C2)Cl)S(=O)(=O)N ;
	InChI InChI=1S/C13H19ClN2O5S2/c1-13(6-3-7-21-13)9-16(2)23(19,20)10-4-5-11(14)12(8-10)22(15,17)18/h4-5,8H,3,6-7,9H2,1-2H3,(H2,15,17,18) ; Key:SMNOERSLNYGGOU-UHFFFAOYSA-N ;
(what is this?) (verify)

Mefruside (INN) is a diuretic indicated for the treatment of edema and hypertension.^[1]

It was developed by Bayer A.G. and is sold under the tradename Baycaron.

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.

Systematic (IUPAC) name
File:Mefruside.png
4-chloro-N¹-methyl-N¹-[(2-methyltetrahydrofuran-2-yl)methyl]benzene-1,3-disulfonamide
Clinical data
AHFS/Drugs.com	International Drug Names
Legal status	℞ (Prescription only)
Routes of administration	Oral
Identifiers
CAS Number	7195-27-9^Y
ATC code	C03BA05 (WHO)
PubChem	CID: 4047
ChemSpider	3907^N
UNII	X1NS9SNS92^Y
KEGG	D01877^Y
Chemical data
Formula	C₁₃H₁₉ClN₂O₅S₂
Molecular mass	382.88 g/mol
SMILES CC1(CCCO1)CN(C)S(=O)(=O)C2=CC(=C(C=C2)Cl)S(=O)(=O)N
InChI InChI=1S/C13H19ClN2O5S2/c1-13(6-3-7-21-13)9-16(2)23(19,20)10-4-5-11(14)12(8-10)22(15,17)18/h4-5,8H,3,6-7,9H2,1-2H3,(H2,15,17,18)^N Key:SMNOERSLNYGGOU-UHFFFAOYSA-N^N

^NY (what is this?) (verify)